Drug
Safusidenib
Safusidenib: highest development phase Phase 2, developed by Nuvation Bio Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Nuvation Bio Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| Safusidenib NCT07703436 | Phase 2 | Grade 2 IDH1-mutant Glioma |
Latest
No recent events.
Follow Safusidenib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.